Home Biosimilar Antibodies Transmembrane Transporters CD markers Daratumumab (anti-CD38) For research use only.
Not for use in humans.

Daratumumab (anti-CD38)

Daratumumab (anti-CD38) is a recombinant monoclonal antibody to CD38. Daratumumab is an investigational anti-cancer drug which is indicated for the treatment of adult patients with multiple myeloma. MW =145.4 kDa.

Daratumumab (anti-CD38)

Click to purchase the isotype control of Daratumumab (anti-CD38)

Selleck's Daratumumab (anti-CD38) has been cited by 1 Publication

Purity & Quality Control

Batch: Purity: 99% Protein concentration: 5.72 mg/ml Endotoxin Level: ＜1EU/mg
99

Choose Selective CD markers Inhibitors

Biological Activity

Description Daratumumab (anti-CD38) is a recombinant monoclonal antibody to CD38. Daratumumab is an investigational anti-cancer drug which is indicated for the treatment of adult patients with multiple myeloma. MW =145.4 kDa.

Product Details

CAS No. 945721-28-8
Isotype Human IgG1
Source Human
Formulation PBS Buffer, PH 7.4
Storage
(From the date of receipt)		 Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Daratumumab (anti-CD38) | Daratumumab (anti-CD38) supplier | purchase Daratumumab (anti-CD38) | Daratumumab (anti-CD38) cost | Daratumumab (anti-CD38) manufacturer | order Daratumumab (anti-CD38) | Daratumumab (anti-CD38) distributor